Mayo Clinic expert explains new vaccine options for next influenza season

July 16, 2013

The next flu shot season will include several new vaccine options for consumers, Mayo Clinic vaccine expert Gregory Poland, M.D., says. Fearful of needles? There's now an influenza vaccination just for you. Allergic to eggs? It won't stop you from getting a flu shot. The new choices move influenza vaccinations closer to the personalized approach long sought by immunologists including Dr. Poland, but they may also prove bewildering to patients, he says.

"I think what's really going to be confusing to patients and to doctors and nurses is that we'll have seven different choices this year. We're used to the , we're used to the nasal spray, and that's all we've had, forever," says Dr. Poland, who heads the Mayo Clinic Vaccine Research Group and the Mayo Clinic Program in Translational Immunovirology and Biodefense.

The new options available for the upcoming include:

*A shot with four strains of influenza rather than the traditional three strains.

*Nasal sprays with four strains rather than the usual three strains.

*A high-dose vaccine for the elderly, to boost their immune response and protection.

*For those with , two new vaccines without egg proteins.

*For the needle-phobic, a new vaccine delivered by a tiny needle called a micro-needle into the skin, rather than by a regular needle under the skin.

"So lots of choices of different kinds of vaccines that tend to be targeted toward individual age groups and fears, for example a needle fear. It really is ushering in a new era of individualized, or personalized, medicine," Dr. Poland says. "Instead of 'one size fits all,' this is a very real example of the incredible advances happening in medicine, where there's not one choice for everybody, there's a best choice for each individual, and that's what's happening with flu vaccines."

Work by Dr. Poland and the Mayo Clinic Vaccine Research Group includes research into what they call "vaccinomics"  — the development of personalized vaccines based on the growing understanding of the role genetics play in how and why people respond to vaccines differently, including influenza vaccines.

Explore further: FDA approves first 4-in-1 flu vaccine

Related Stories

FDA approves first 4-in-1 flu vaccine

February 29, 2012

Federal health officials have approved the first vaccine that protects against four strains of the common flu, offering one additional layer of protection against the influenza virus that affects millions each year.

Recommended for you

Monkeys in Asia harbor virus from humans, other species

November 19, 2015

When it comes to spreading viruses, bats are thought to be among the worst. Now a new study of nearly 900 nonhuman primates in Bangladesh and Cambodia shows that macaques harbor more diverse astroviruses, which can cause ...

One-step test for hepatitis C virus infection developed

November 14, 2015

UC Irvine Health researchers have developed a cost-effective one-step test that screens, detects and confirms hepatitis C virus (HCV) infections. Dr. Ke-Qin Hu, director of hepatology services, will present findings at the ...

Computer model reveals deadly route of Ebola outbreak

November 10, 2015

Using a novel statistical model, a research team led by Columbia University's Mailman School of Public Health mapped the spread of the 2014-2015 Ebola outbreak in Sierra Leone, providing the most detailed picture to date ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.